These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 19280230)
1. [Correlation between quantitative sensory testing and questionnaires on neuropathic pain for chronic ischemic pain in peripheral arterial disease]. Lang PM; Rüger LJ; Abahji T; Hoffmann U; Crispin A; Irnich D Schmerz; 2009 Jun; 23(3):251-4, 256-8. PubMed ID: 19280230 [TBL] [Abstract][Full Text] [Related]
2. Characteristics of chronic ischemic pain in patients with peripheral arterial disease. Rüger LJ; Irnich D; Abahji TN; Crispin A; Hoffmann U; Lang PM Pain; 2008 Sep; 139(1):201-208. PubMed ID: 18472216 [TBL] [Abstract][Full Text] [Related]
3. [Pain and QST:.."measure what is measurable"...]. Baron R; Tölle TR Schmerz; 2009 Feb; 23(1):5-6. PubMed ID: 19198887 [No Abstract] [Full Text] [Related]
4. [Procedure for certification of QST laboratories]. Geber C; Scherens A; Pfau D; Nestler N; Zenz M; Tölle T; Baron R; Treede RD; Maier C Schmerz; 2009 Feb; 23(1):65-9. PubMed ID: 19184121 [TBL] [Abstract][Full Text] [Related]
5. Quantitative sensory testing in measurement of neuropathic pain phenomena and other sensory abnormalities. Backonja MM; Walk D; Edwards RR; Sehgal N; Moeller-Bertram T; Wasan A; Irving G; Argoff C; Wallace M Clin J Pain; 2009 Sep; 25(7):641-7. PubMed ID: 19692807 [TBL] [Abstract][Full Text] [Related]
6. Reduced intraepidermal nerve fiber density in patients with chronic ischemic pain in peripheral arterial disease. Gröne E; Üçeyler N; Abahji T; Fleckenstein J; Irnich D; Mussack T; Hoffmann U; Sommer C; Lang PM Pain; 2014 Sep; 155(9):1784-1792. PubMed ID: 24931568 [TBL] [Abstract][Full Text] [Related]
7. Validation of a Brazilian quantitative sensory testing (QST) device for the diagnosis of small fiber neuropathies. Schestatsky P; Stefani LC; Sanches PR; Silva Júnior DP; Torres IL; Dall-Agnol L; Balbinot LF; Caumo W Arq Neuropsiquiatr; 2011 Dec; 69(6):943-8. PubMed ID: 22297885 [TBL] [Abstract][Full Text] [Related]
8. Can self-reported pain characteristics and bedside test be used for the assessment of pain mechanisms? An analysis of results of neuropathic pain questionnaires and quantitative sensory testing. Gierthmühlen J; Schneider U; Seemann M; Freitag-Wolf S; Maihöfner C; Enax-Krumova EK; Azad SC; Üçeyler N; Birklein F; Maier C; Tölle T; Treede RD; Baron R Pain; 2019 Sep; 160(9):2093-2104. PubMed ID: 31162335 [TBL] [Abstract][Full Text] [Related]
9. Sensory profiles of patients with neuropathic pain based on the neuropathic pain symptoms and signs. Freeman R; Baron R; Bouhassira D; Cabrera J; Emir B Pain; 2014 Feb; 155(2):367-376. PubMed ID: 24472518 [TBL] [Abstract][Full Text] [Related]
10. Neurophysiologic and quantitative sensory testing in the diagnosis of trigeminal neuropathy and neuropathic pain. Jääskeläinen SK; Teerijoki-Oksa T; Forssell H Pain; 2005 Oct; 117(3):349-357. PubMed ID: 16153774 [TBL] [Abstract][Full Text] [Related]
12. Concurrent validity of a low-cost and time-efficient clinical sensory test battery to evaluate somatosensory dysfunction. Zhu GC; Böttger K; Slater H; Cook C; Farrell SF; Hailey L; Tampin B; Schmid AB Eur J Pain; 2019 Nov; 23(10):1826-1838. PubMed ID: 31325385 [TBL] [Abstract][Full Text] [Related]
13. Sensory neuropathy and signs of central sensitization in patients with peripheral arterial disease. Lang PM; Schober GM; Rolke R; Wagner S; Hilge R; Offenbächer M; Treede RD; Hoffmann U; Irnich D Pain; 2006 Sep; 124(1-2):190-200. PubMed ID: 16716518 [TBL] [Abstract][Full Text] [Related]
14. Differences and similarities between atypical facial pain and trigeminal neuropathic pain. Forssell H; Tenovuo O; Silvoniemi P; Jääskeläinen SK Neurology; 2007 Oct; 69(14):1451-9. PubMed ID: 17909158 [TBL] [Abstract][Full Text] [Related]
15. Pain ratings at the thresholds are necessary for interpretation of quantitative sensory testing. Kelly KG; Cook T; Backonja MM Muscle Nerve; 2005 Aug; 32(2):179-84. PubMed ID: 15937874 [TBL] [Abstract][Full Text] [Related]
17. Test-retest and interobserver reliability of quantitative sensory testing according to the protocol of the German Research Network on Neuropathic Pain (DFNS): a multi-centre study. Geber C; Klein T; Azad S; Birklein F; Gierthmühlen J; Huge V; Lauchart M; Nitzsche D; Stengel M; Valet M; Baron R; Maier C; Tölle T; Treede RD Pain; 2011 Mar; 152(3):548-556. PubMed ID: 21237569 [TBL] [Abstract][Full Text] [Related]
18. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): reference data for the trunk and application in patients with chronic postherpetic neuralgia. Pfau DB; Krumova EK; Treede RD; Baron R; Toelle T; Birklein F; Eich W; Geber C; Gerhardt A; Weiss T; Magerl W; Maier C Pain; 2014 May; 155(5):1002-1015. PubMed ID: 24525274 [TBL] [Abstract][Full Text] [Related]
19. Impact of endovascular intervention on pain and sensory thresholds in nondiabetic patients with intermittent claudication: a pilot study. Lang PM; Vock G; Schober GM; Kramer S; Abahji T; Crispin A; Irnich D; Hoffmann U J Pain; 2009 Mar; 10(3):264-73. PubMed ID: 19010739 [TBL] [Abstract][Full Text] [Related]
20. Usefulness of laser-evoked potentials and quantitative sensory testing in the diagnosis of neuropathic spinal cord injury pain: a multiple case study. Landmann G; Berger MF; Stockinger L; Opsommer E Spinal Cord; 2017 Jun; 55(6):575-582. PubMed ID: 28117333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]